DETERMINATION OF THE MOLECULAR-WEIGHT DISTRIBUTION OF LOW-MOLECULAR-WEIGHT HEPARINS USING HIGH-PERFORMANCE GEL-PERMEATION CHROMATOGRAPHY

被引:0
作者
KOMATSU, H
TAKAHATA, T
TANAKA, M
ISHIMITSU, S
OKADA, S
机构
[1] OSAKA COLL PHARM, MATSUBARA, OSAKA 580, JAPAN
[2] KYUSHU UNIV, FAC PHARMACEUT SCI, HIGASHI KU, FUKUOKA 812, JAPAN
关键词
LOW-MOLECULAR-WEIGHT HEPARIN; MOLECULAR-WEIGHT DISTRIBUTION; HEPARIN; HIGH-PERFORMANCE GEL PERMEATION CHROMATOGRAPHY; POLYSACCHARIDE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The molecular-weight distribution of commercially available low-molecular-weight heparins (LMWHs) was estimated by high-performance gel permeation chromatography (HPGPC) using a LMWH molecular-weight calibrant, supplied by the National Institute for Biological Standards and Control for the calibration of columns. This calibrant is a mixture of many polysaccharides with a disaccharide unit prepared by a random depolymerization of unfractionated heparin, and the ends of the fragments have a UV absorption. The ratio of the refractive index to the UV absorption is a relative measure of molecular weight. Various molecular-weight parameters such as weight-, number- or z-average molecular-weights, polydispersity and relative distributions of high, middle and low molecular-weight components were estimated, indicating that LMWHs have a wide variation in molecular-weight distribution. This variation was ascribed to the difference in preparation methods from unfractionated heparins.
引用
收藏
页码:1189 / 1193
页数:5
相关论文
共 24 条
[1]   MACROMOLECULAR PROPERTIES AND BIOLOGICAL ACTIVITY OF HEPARIN [J].
BARLOW, GH ;
SANDERSON, ND ;
MCNEILL, PD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1961, 94 (03) :518-&
[2]   STRUCTURE AND BIOLOGICAL-ACTIVITY OF HEPARIN [J].
CASU, B .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1985, 43 :51-134
[3]  
DIETRICH CP, 1980, MECHANISM SACCHARIDE, P317
[4]  
FAREED J, 1989, ANN NY ACAD SCI, V556, P333
[5]  
FAREED J, 1988, HAEMOSTASIS, V18, P3
[6]   CHEMICAL AND BIOLOGICAL HETEROGENEITY IN LOW-MOLECULAR WEIGHT HEPARINS - IMPLICATIONS FOR CLINICAL USE AND STANDARDIZATION [J].
FAREED, J ;
WALENGA, JM ;
HOPPENSTEADT, D ;
RACANELLI, A ;
COYNE, E .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (04) :440-463
[7]   METACHROMATIC ACTIVITY OF HEPARIN AND HEPARIN FRAGMENTS [J].
GRANT, AC ;
LINHARDT, RJ ;
FITZGERALD, GL ;
PARK, JJ ;
LANGER, R .
ANALYTICAL BIOCHEMISTRY, 1984, 137 (01) :25-32
[8]   CHARACTERIZATION OF HEPARINS BY HIGH-PERFORMANCE SIZE EXCLUSION LIQUID-CHROMATOGRAPHY [J].
HARENBERG, J ;
DEVRIES, JX .
JOURNAL OF CHROMATOGRAPHY, 1983, 261 (02) :287-292
[9]   STANDARDIZATION OF HEPARINS BY MEANS OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY EQUIPPED WITH A LOW-ANGLE LASER-LIGHT SCATTERING DETECTOR [J].
HENNINK, WE ;
VANDENBERG, JWA ;
FEIJEN, J .
THROMBOSIS RESEARCH, 1987, 45 (05) :463-475
[10]  
HIRSH J, 1987, THROMB DIATH HAEMO, P348